Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Infections and lupus]

V Le Moing1, C Leport

  • 1Service des Maladies infectieuses et tropicales, Hôpital Bichat-Claude-Bernard, Paris.

La Revue Du Praticien
|October 22, 1998
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) patients face high infection risks due to immune dysfunction and treatments. Early antibiotic therapy and cotrimoxazole prophylaxis are crucial for managing infections like Pneumocystis pneumonia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19: The forgotten cases of hidden exiles.

Infectious diseases now·2021
Same author

Increased risks of SARS-CoV-2 nosocomial acquisition in high-risk COVID-19 units justify personal protective equipment: a cross-sectional study.

The Journal of hospital infection·2020
Same author

2010 French SPILF-AFSSAPS guiding criteria for Streptococcuspneumoniae acute community-acquired pneumonia: Evaluation in patients of the PACSCAN-ESCAPED cohort.

Infectious diseases now·2020
Same author

Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.

The Journal of infection·2020
Same author

Multi-sectorial research is paramount for preventing and controlling emerging infectious diseases.

Revue d'epidemiologie et de sante publique·2019
Same author

Implant retention and high rate of treatment failure in hematogenous acute knee and hip prosthetic joint infections.

Medecine et maladies infectieuses·2019
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Immunology
  • Infectious Diseases
  • Rheumatology

Background:

  • Infections are a primary cause of morbidity and mortality in systemic lupus erythematosus (SLE).
  • Immune system dysfunctions, glomerulonephritis, and treatments like high-dose corticosteroids or immunosuppressors predispose SLE patients to infections.
  • Opportunistic infections, including candidiasis and Pneumocystis carinii pneumonia, are increasing with intensive therapeutic strategies.

Purpose of the Study:

  • To review the major causes of infection in SLE patients.
  • To identify predisposing factors and common infections in SLE.
  • To provide recommendations for managing infections in SLE.

Main Methods:

  • Literature review of infections in systemic lupus erythematosus.

Related Experiment Videos

  • Analysis of predisposing factors and common pathogens.
  • Evaluation of current treatment strategies and prophylaxis.

    • Main Results:

    • Community-acquired microorganisms cause the most frequent infections in SLE patients.
    • Opportunistic infections are associated with disease severity and immunosuppressive therapy.
    • Empirical antibiotic treatment is recommended for febrile SLE patients.

    Conclusions:

    • Prompt initiation of empirical antibiotic treatment is justified for febrile SLE patients.
    • Cotrimoxazole prophylaxis is recommended for SLE patients with significant lymphopenia to prevent Pneumocystis carinii pneumonia.